Get started
Author

Danielle Angela Ferraro

Observed names: D. Ferraro, Danielle A Ferraro, Danielle Ferraro, Ferraro, Danielle, Ferraro, Danielle A.
ORCID: 0000-0002-8791-7692
Observed ORCID: 0000-0002-8791-7692
OpenAlex ID: A5079686267
Panitumumab added to docetaxel, cisplatin and fluoropyrimidine in oesophagogastric cancer: ATTAX3 phase II trial
2016 · on behalf of the Australasian Gastro-Intestinal Trials Group (AGITG), Niall C Tebbutt, et al. · British Journal of Cancer · 47
PDF
A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trial
2015 · A. Davidson, A.-S. Veillard, et al. · Annals of Oncology · 34
Regorafenib in gastrointestinal stromal tumors: clinical evidence and place in therapy
2014 · Danielle Ferraro, John Zalcberg · Therapeutic Advances in Medical Oncology · 33
Synergistic targeting of BRCA1 mutated breast cancers with PARP and CDK2 inhibition
2021 · Diar Aziz, Neil Portman, et al. · npj Breast Cancer · 22
PDF
TACTIC: a multicentre, open-label, single-arm phase II trial of panitumumab, cisplatin, and gemcitabine in biliary tract cancer
2016 · behalf of the the Australasian Gastro-Intestinal Trials Group, D. Ferraro, et al. · Cancer Chemotherapy and Pharmacology · 17
Discussing and prescribing expensive unfunded anticancer drugs in Australia
2017 · Deme John Karikios, Linda Mileshkin, et al. · ESMO Open · 6
PDF
Final results of AGITG ATTAX3 study: Randomized phase II study of weekly docetaxel (T), cisplatin, and fluoropyrimidine (F) with or without panitumumab (P) in advanced esophagogastric (OG) cancer.
2013 · Niall C. Tebbutt, Timothy Jay Price, et al. · Journal of Clinical Oncology · 5
KRAS and BRAF mutational status and PTEN, cMET, and IGF1R expression as predictive markers of response to cetuximab plus chemotherapy in metastatic colorectal cancer (mCRC).
2010 · M. Di Salvatore, A. Inno, et al. · Journal of Clinical Oncology · 4
Human equilibrative nucleoside transporter 1 (hENT1) in gemcitabine and FOLFOX (oxaliplatin, 5-fluorouracil, and leucovorin)-treated patients with metastatic pancreatic cancer: The randomized phase II PAN1 study.
2014 · Yu Jo Chua, Christos Stelios Karapetis, et al. · Journal of Clinical Oncology · 3
1202 Discussing and prescribing expensive unfunded anticancer drugs in Australia
2015 · D. Karikios, L. Mileshkin, et al. · European Journal of Cancer · 2
PDF
Metadata record for the article: Synergistic targeting of BRCA1 mutated breast cancers with PARP and CDK2 inhibition
2021 · Aziz, Diar, Portman, Neil, et al. · Figshare · 1
Associations of incidence of common adverse events (AEs) and survival outcomes in metastatic colorectal cancer (mCRC) patients (pts) treated with first line chemotherapy: Findings from 9,812 pts in the ARCAD database.
2018 · Danielle Angela Ferraro, John Raymond Zalcberg, et al. · Journal of Clinical Oncology · 1
Impact of overall severity of adverse events (AEs) on long-term outcomes in metastatic colorectal cancer (mCRC) patients (pts) treated with first line systemic chemotherapy: Findings from 3,971 pts in the ARCAD database.
2017 · John Raymond Zalcberg, Qian Shi, et al. · Journal of Clinical Oncology · 1
Patient Versus Clinician Preferences for Chemotherapy in Non-Small-Cell Lung Cancer
2013 · Anne Long, Danielle Ferraro, et al. · Lung Cancer Management · 1
298O The clinical significance of deregulated cyclin E1 in high grade serous ovarian cancer (HGSOC)
2016 · D. Aziz, D. Etemadmoghadam, et al. · Annals of Oncology
PDF
298O The clinical significance of deregulated cyclin E1 in high grade serous ovarian cancer (HGSOC)
2016 · D. Aziz, D. Etemadmoghadam, et al. · Annals of Oncology
Rare data for a common cancer: survival outcomes for metastatic breast cancer (MBC) at Eastern Health, Victoria, Australia
2015 · Ferraro, Danielle A., Soo, Wee-Kheng, et al. · Deakin Research Online (Deakin University)
SMALL CELL LuNg CANCER uPDATE
2013 · Danielle Ferraro, Michael Millward · UWA Profiles and Research Repository (UWA)
Australian perspective on the role of targeted therapies in gastroesophageal cancer
2011 · Sid Deb, Danielle Ferraro, et al. · Cancer Forum
Works count: 19
Citation count: 177
H-index: 6
I10-index: 5
Year
Topic
Type